Goldman Sachs’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$155M Buy
469,388
+94,065
+25% +$32M 0.02% 801
2025
Q4
$149M Sell
375,323
-163,023
-30% -$72.1M 0.02% 767
2025
Q3
$245M Sell
538,346
-6,970
-1% -$2.84M 0.04% 523
2025
Q2
$178M Buy
545,316
+121,949
+29% +$33.7M 0.03% 608
2025
Q1
$114M Buy
423,367
+116,912
+38% +$30M 0.02% 723
2024
Q4
$72.1M Sell
306,455
-49,645
-14% -$13.1M 0.01% 1006
2024
Q3
$97.9M Sell
356,100
-158,567
-31% -$41.3M 0.02% 805
2024
Q2
$125M Buy
514,667
+254,648
+98% +$40.2M 0.02% 688
2024
Q1
$38.9M Sell
260,019
-31,349
-11% -$5.23M 0.01% 1327
2023
Q4
$55.8M Sell
291,368
-20,677
-7% -$3.52M 0.01% 1110
2023
Q3
$55.3M Buy
312,045
+56,152
+22% +$10.7M 0.01% 1050
2023
Q2
$48.6M Buy
255,893
+25,707
+11% +$5.1M 0.01% 1129
2023
Q1
$46.1M Sell
230,186
-162,575
-41% -$34.2M 0.01% 1122
2022
Q4
$93.3M Sell
392,761
-72,546
-16% -$15.5M 0.03% 755
2022
Q3
$93.1M Sell
465,307
-12,067
-3% -$2.3M 0.03% 719
2022
Q2
$69.6M Sell
477,374
-204,179
-30% -$29M 0.02% 898
2022
Q1
$111M Sell
681,553
-5,142
-0.7% -$783K 0.03% 707
2021
Q4
$116M Buy
686,695
+20,240
+3% +$3.76M 0.03% 721
2021
Q3
$126M Sell
666,455
-35,591
-5% -$6.68M 0.03% 620
2021
Q2
$119M Buy
702,046
+7,736
+1% +$1.13M 0.03% 627
2021
Q1
$98M Sell
694,310
-19,075
-3% -$2.87M 0.03% 664
2020
Q4
$92.7M Buy
713,385
+125,825
+21% +$16.8M 0.03% 673
2020
Q3
$85.5M Sell
587,560
-497,516
-46% -$70.7M 0.03% 654
2020
Q2
$161M Buy
1,085,076
+304,814
+39% +$41.1M 0.06% 383
2020
Q1
$84.9M Sell
780,262
-57,442
-7% -$6.63M 0.03% 581
2019
Q4
$96.5M Sell
837,704
-309,664
-27% -$30.9M 0.03% 716
2019
Q3
$92.3M Buy
1,147,368
+227,197
+25% +$18M 0.03% 709
2019
Q2
$66.8M Sell
920,171
-96,842
-10% -$7.43M 0.02% 958
2019
Q1
$95M Sell
1,017,013
-102,375
-9% -$8.56M 0.03% 694
2018
Q4
$81.6M Buy
1,119,388
+178,810
+19% +$13.8M 0.03% 734
2018
Q3
$82.3M Buy
940,578
+111,679
+13% +$11.2M 0.02% 886
2018
Q2
$81.6M Sell
828,899
-181,839
-18% -$18M 0.03% 873
2018
Q1
$120M Sell
1,010,738
-176,806
-15% -$22.8M 0.04% 666
2017
Q4
$151M Sell
1,187,544
-606,207
-34% -$76.2M 0.04% 590
2017
Q3
$211M Buy
1,793,751
+282,039
+19% +$24.1M 0.07% 399
2017
Q2
$121M Buy
1,511,712
+127,718
+9% +$8.16M 0.04% 656
2017
Q1
$70.9M Buy
1,383,994
+469,557
+51% +$21.7M 0.02% 985
2016
Q4
$34.2M Sell
914,437
-28,422
-3% -$1.19M 0.01% 1552
2016
Q3
$63.9M Buy
942,859
+249,691
+36% +$17.6M 0.03% 1013
2016
Q2
$38.5M Buy
693,168
+51,294
+8% +$3.23M 0.02% 1310
2016
Q1
$40.3M Buy
641,874
+248,739
+63% +$16.5M 0.02% 1228
2015
Q4
$37M Buy
393,135
+67,369
+21% +$6.25M 0.02% 1336
2015
Q3
$26.2M Sell
325,766
-59,811
-16% -$6.65M 0.01% 1524
2015
Q2
$46.2M Sell
385,577
-209,528
-35% -$25M 0.02% 1170
2015
Q1
$62.1M Buy
595,105
+38,829
+7% +$3.93M 0.03% 934
2014
Q4
$54M Sell
556,276
-14,829
-3% -$1.37M 0.02% 1033
2014
Q3
$44.6M Buy
571,105
+7,994
+1% +$516K 0.02% 1158
2014
Q2
$35.6M Buy
563,111
+50,522
+10% +$3M 0.01% 1357
2014
Q1
$34.4M Buy
512,589
+71,839
+16% +$5.56M 0.02% 1327
2013
Q4
$28.3M Buy
440,750
+91,961
+26% +$5.49M 0.01% 1482
2013
Q3
$22.3M Sell
348,789
-203,530
-37% -$10.1M 0.01% 1538
2013
Q2
$17.1M Buy
+552,319
New +$14.7M 0.01% 1656

Other funds holding ALNY